Showing results (541-550 of 654) with videos related to

Sort By:
Pageof 66
European Heart Journal. Cardiovascular Pharmacotherapy|January 13, 2023
Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysisGerasimos Filippatos, Stefan D Anker, Phyllis August, et al.
Immunologic Research|June 21, 2015
Are human endogenous retroviruses triggers of autoimmune diseases? Unveiling associations of three diseases and viral lociBjørn A Nexø, Palle Villesen, Kari K Nissen, et al.
Scientific Reports|May 20, 2021
The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetesSuvanjaa Sivalingam, Emil List Larsen, Daniel H van Raalte, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 1, 2021
Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trialDavid C Wheeler, Niels Jongs, Bergur V Stefansson, et al.
Kidney International|April 20, 2021
A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathyDavid C Wheeler, Robert D Toto, Bergur V Stefánsson, et al.
Genes|May 27, 2023
Differential Methylation of Telomere-Related Genes Is Associated with Kidney Disease in Individuals with Type 1 DiabetesClaire Hill, Seamus Duffy, Laura M Kettyle, et al.
The Lancet. Diabetes & Endocrinology|November 28, 2024
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trialsSunil V Badve, Anika Bilal, Matthew M Y Lee, et al.
Ebiomedicine|January 3, 2025
Genetic factors shaping the plasma lipidome and the relations to cardiometabolic risk in children and adolescentsYun Huang, Sara Elizabeth Stinson, Malte Thodberg, et al.
Hypertension (Dallas, Tex. : 1979)|June 5, 2026
Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood PressureRajiv Agarwal, Ricardo Correa-Rotter, Sankar D Navaneethan, et al.
Clinical Kidney Journal|August 12, 2024
The validity of pathology codes for biopsy-confirmed kidney disease in the Danish National PatobankMarie Møller, Iain Bressendorff, Rikke Borg, et al.
Pageof 66